FindTrial
Sign In

Study conducted in a tertiary care hospital for a period of one year, aims to observe the number of new cases and better understand the treatment of infections caused by bacteria belonging to Enterobacteriaceae species that are resistant to an antibiotic class called Carbapenems.

Management of Carbapenem Resistant Enterobacteriaceae infection - a cross sectional study in a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051953
Enrollment
139
Registered
2023-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J150- Pneumonia due to Klebsiella pneumoniae Health Condition 2: A415- Sepsis due to other Gram-negativeorganisms Health Condition 3: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

Gaurav Girish
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ADULT PATIENT WITH CRE INFECTION CAUSED BY E.COLI OR K.PNEUMONIAE

Exclusion criteria

Exclusion criteria: PATIENTS WHO DO NOT PROVIDE CONSENT

Design outcomes

Primary

MeasureTime frame
INCIDENCE OF CRE INFECTIONS and COMPARISION OF MANAGEMENT GUIDELINES FOLLOWED IN TERTIARY CARE HOSPITAL WITH ICMR GUIDELINESTimepoint: April 2023 to March 2024—

Secondary

MeasureTime frame
COMPARISION OF MANAGEMENT WITH ICMR GUIDELINESTimepoint: MAY 2023 TO MAY 2024—

Countries

India

Contacts

Public ContactGaurav Girish

Manipal College of Pharmaceutical Sciences

prasanna.shetty@manipal.edu07019950009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026